drugset / Trial / NCT03576508

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

NCT03576508

Phase 1 Completed 16 enrolled Centrexion Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

This is a Phase 1b, open-label, two-period, randomized crossover study in adult male and female participants with painful knee osteoarthritis.

Timeline

Start
2018-06-25
Primary completion
2018-09-06
Completion
2018-09-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CNTX-4975-05 Unknown 1 mg Other
Comparator Capsaicin Small molecule 8 % Topical
Background Lidocaine Other / unclassified 2 % Other
Background Lidocaine Other / unclassified 15 ml Other

Indications